Inventia enters the U.S. market with FDA approved Dapagliflozin tablets EP News Bureau Apr 8, 2026 Approval grants eligibility for 180-day shared generic drug exclusivity
Keynote Address by Dr Pavan Bhat, CEO, Inventia Healthcare EP News Bureau Jul 6, 2025 Day two at the FDD Conclave 2025 began with a highly insightful and motivating keynote address by Dr Pavan Bhat, CEO, Inventia…
